Log in
Subscribe
Saturday, June 14, 2025

Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases With Data Showing Summit’s Ridinilazole Achieved Statistical Superiority over Vancomycin in the Treatment of C. Difficile Infection




News Story – QuoteMedia Market Data Solutions




Share:

Linkedin X-twitter Facebook Youtube

Premium Content

• Analytics: Data, Dashboards, Knowledge

• EnerCom Conference Replays

• Exclusive Executive  Interviews

Subscribe
Oil & Gas
Oilfield Services
Energy Transition
Regions
Finance
360 Energy Expert Network
Press Releases
Oil & Gas 360® is a one-stop source of news, information, and analysis from the professionals at EnerCom, Inc.  The website is dedicated to all things energy: people, technologies, transactions, trends, and macro-economic analysis that impact commodity prices. © 2024 Oil & Gas 360®. All Rights Reserved. Oil & Gas 360® P.O. Box 100938 Denver, CO 80250
Linkedin X-twitter Facebook Youtube

Sign up to receive daily news and stock prices from Oil & Gas 360® directly in your email inbox. 

Name

Market Data ©2020–2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.